Italian Startup Raises $5.4M for Robotic Exoskeletons

Jan de Vries · 2026-04-03

Here's some news that feels like it's straight out of a sci-fi movie, but it's happening right now in Italy. Wearable Robotics, a startup from Pisa, just secured a major Series A funding round. We're talking about $5.4 million to scale their neuromotor rehabilitation robotics and exoskeleton technology globally. It's a big deal for a company that's essentially building real-life assistive tech. The kind that helps people walk again or regain movement after an injury. Let's break down what this means and why you should care, even if you're not in the medical field. ### Who's Backing This Vision? The funding round wasn't just a single check. It was led by CDP Venture Capital's Accelerators Fund. They had a whole crew of co-investors join in, including MITO Technology, LIFTT, and SIMEST. It also involved RoboIT, the National Technology Transfer Hub for Robotics, and the Toscana Next fund. That last one is interesting—it's managed by CDP and backed by major Tuscan banking foundations. Think Fondazione CR Firenze and Fondazione Monte dei Paschi di Siena. The message is clear: there's serious local and national belief in this company's potential to put Italian innovation on the world map. Lucia Lencioni, the CEO, put it perfectly: > "We are building the foundation for sustainable and scalable growth, while simultaneously investing in product innovation, regulatory strength and commercial development." In other words, this cash isn't just for dreaming bigger. It's for doing the hard work to make those dreams a widespread reality. ### What Does Wearable Robotics Actually Do? Founded back in 2014 as a spin-off from the prestigious Scuola Superiore Sant'Anna, this company is in the business of augmentation. They create wearable robotic devices and exoskeletons with two main goals: - Helping patients recover neuromotor functions (rehabilitation). - Assisting workers with physical tasks (industrial support). They've cleverly split their efforts into two divisions to tackle these markets head-on. ### The Two Sides of the Business First, there's **NEXUM Medical**. This is the branch focused purely on healthcare. They design and manufacture robotic devices, primarily for upper limb rehabilitation. Their solutions often blend physical robotics with virtual and augmented reality (VR/AR) systems. The idea is to make rehab more engaging, measurable, and effective, with a sharp focus on helping patients regain skills for daily living. Then you have **NEXUM Industry**. This side develops exoskeletons for the workplace. Imagine a warehouse worker lifting heavy boxes all day. An industrial exoskeleton provides supportive force, reducing fatigue and cutting down on musculoskeletal injuries. It's about human strength amplification and safety. ### The Flagship Product and Future Plans Right now, their star is the ALEX RS. It's a bilateral device for upper limb neuromotor rehab, and they've already installed over 50 units internationally. That's a solid foothold. This new funding is fuel for their next steps: - Expanding their product portfolio beyond this flagship. - Strengthening their commercial channels to grow their global presence. - Navigating complex regulatory processes in key markets like the US to speed up time-to-market. It's a classic scale-up playbook: solidify your tech, then conquer new territories. ### Why This Matters Beyond the Headline This isn't just another startup funding story. It's a signal. The convergence of robotics, healthcare, and industrial safety is accelerating. For professionals watching the medtech and industrial automation spaces, Wearable Robotics represents a compelling case study in focused, dual-market innovation. They're not trying to build a robot for everything. They're mastering specific, high-impact applications where wearable tech can change lives and improve workplaces. With $5.4 million in new capital and a clear roadmap, they're one to watch as they move from an Italian innovator to a global contender.